IBRANCE Summary Product Information

palbociclib

(

Route of Administration	Pharmaceutical Form/Strength	Clinically Relevant Nonmedicinal Ingredients
Oral	Capsules 75 mg, 100 mg, 125 mg	Lactose monohydrate For a complete listing see Dosage Forms, Composition and Packaging section.
Oral	Tablets 75 mg, 100 mg, 125 mg	None For a complete listing see Dosage Forms, Composition and Packaging section.

Route of Administration

Pharmaceutical Form/Strength

Clinically Relevant Nonmedicinal Ingredients

Oral

Capsules 75 mg, 100 mg, 125 mg

Lactose monohydrate

For a complete listing see Dosage Forms, Composition and Packaging section.

Oral

Tablets 75 mg, 100 mg, 125 mg

None

For a complete listing see Dosage Forms, Composition and Packaging section.

)

Find IBRANCE medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

IBRANCE Quick Finder

Product Monograph

Download Product Monograph

Health Professional Information

Summary Product Information

Route of Administration	Pharmaceutical Form/Strength	Clinically Relevant Nonmedicinal Ingredients
Oral	Capsules 75 mg, 100 mg, 125 mg	Lactose monohydrate For a complete listing see Dosage Forms, Composition and Packaging section.
Oral	Tablets 75 mg, 100 mg, 125 mg	None For a complete listing see Dosage Forms, Composition and Packaging section.

Route of Administration

Pharmaceutical Form/Strength

Clinically Relevant Nonmedicinal Ingredients

Oral

Capsules 75 mg, 100 mg, 125 mg

Lactose monohydrate

For a complete listing see Dosage Forms, Composition and Packaging section.

Oral

Tablets 75 mg, 100 mg, 125 mg

None

For a complete listing see Dosage Forms, Composition and Packaging section.

Resources

Didn’t find what you were looking for?

Contact us

Call 1-800-463-6001*

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: 1 866 723-7111.

To report an adverse event related to COMIRNATY, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

Canada Vigilance Program

You may also contact the Canada Vigilance Program directly to report adverse events or product quality concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect.